Author:Ilaria De Giovanni

life sciences company

Blogs, Rare diseases

An introduction to PASS studies

News, Rare diseases

Sciensus hosts a panel at the World Orphan Drug Congress 2024

Thought Leadership, Rare diseases

The impact of real-world data in gaining access to the European orphan drugs market. 
Navigating Expanded Access Programs in Europe

Thought Leadership, Rare diseases

Navigating early access in Europe: a strategic blueprint for biotech leaders